A synergistic effect has been reported between deregulated c-Myc and HIF1 to promote hypoxic adaptation in cancer cells via the transcription of VEGF, HX2, and PDHK1, all of which are involved in metabolic reprogramming and angiogenesis [290]. Here, MYC is linked to cancer.